Stocks · Health care · Pharmaceutical Preparations

Lifevantage Corp

LFVN Clue Score55
United States Fiscal year ends December CIK 0000849146 Results filed 27 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Darwin Lewis
15 Sep 2026
Director
Buy
976
$6.22
$6.07K
Kristen Cunningham
14 Sep 2026
Chief Sales Officer
Sell
8,901
$6.18
$55.01K
Kristen Cunningham
11 Sep 2026
Chief Sales Officer
Sell
100
$6.41
$641.00
Darwin Lewis
15 Jun 2026
Director
Buy
705
$8.60
$6.06K
Michael A Beindorff
3 Jun 2026
Director
Sell indirect
10,000
$8.55
$85.46K
Darwin Lewis
16 Mar 2026
Director
Buy
1,055
$5.23
$5.52K
Judd Dayton
2 Mar 2026
Director
Buy
10,500
$4.53
$47.57K
Judd Dayton
27 Feb 2026
Director
Buy
18,097
$4.63
$83.79K
Judd Dayton
26 Feb 2026
Director
Buy
4,600
$4.58
$21.07K
Darwin Lewis
9 Feb 2026
Director
Buy
3,955
$5.22
$20.65K
Darwin Lewis
15 Dec 2025
Director
Buy
805
$6.54
$5.26K
Michael A Beindorff
19 Nov 2025
Director
Sell indirect
12,607
$6.42
$80.93K
Michael A Beindorff
7 Nov 2025
Director
Sell indirect
35,000
$6.92
$242.25K
Michael A Beindorff
7 Nov 2025
Director
Sell
1,000
$7.33
$7.33K

What was left out

Form 4 filings counted 35
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 623,505
History held since 16 Oct 2006